Steve Schonfeld’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-438,062
| Closed | -$46.7M | – | 2626 |
|
|
2025
Q3 | $46.7M | Buy |
438,062
+395,112
| +920% | +$41.3M | 0.27% | 47 |
|
|
2025
Q2 | $4.06M | Buy |
42,950
+31,477
| +274% | +$2.33M | 0.03% | 635 |
|
|
2025
Q1 | $728K | Sell |
11,473
-67,927
| -86% | -$4.06M | ﹤0.01% | 1420 |
|
|
2024
Q4 | $3.69M | Buy |
79,400
+58,978
| +289% | +$2.21M | 0.02% | 606 |
|
|
2024
Q3 | $588K | Sell |
20,422
-201,574
| -91% | -$4.96M | ﹤0.01% | 1363 |
|
|
2024
Q2 | $3.21M | Sell |
221,996
-38,204
| -15% | -$558K | 0.02% | 703 |
|
|
2024
Q1 | $4.19M | Sell |
260,200
-41,800
| -14% | -$723K | 0.03% | 715 |
|
|
2023
Q4 | $6M | Buy |
302,000
+111,594
| +59% | +$1.65M | 0.04% | 479 |
|
|
2023
Q3 | $3.1M | Sell |
190,406
-2,511
| -1% | -$48.4K | 0.02% | 686 |
|
|
2023
Q2 | $4.08M | Sell |
192,917
-142,783
| -43% | -$3.05M | 0.04% | 545 |
|
|
2023
Q1 | $6.74M | Sell |
335,700
-84,097
| -20% | -$1.82M | 0.06% | 367 |
|
|
2022
Q4 | $11M | Buy |
419,797
+360,797
| +612% | +$4.8M | 0.09% | 286 |
|
|
2022
Q3 | $603K | Buy |
59,000
+4,700
| +9% | +$39.6K | 0.01% | 1616 |
|
|
2022
Q2 | $227K | Sell |
54,300
-4,100
| -7% | -$17.5K | ﹤0.01% | 1819 |
|
|
2022
Q1 | $292K | Buy |
58,400
+400
| +0.7% | +$2.33K | ﹤0.01% | 1708 |
|
|
2021
Q4 | $390K | Sell |
58,000
-600
| -1% | -$3.06K | ﹤0.01% | 1396 |
|
|
2021
Q3 | $321K | Buy |
58,600
+400
| +0.7% | +$2.33K | ﹤0.01% | 1489 |
|
|
2021
Q2 | $381K | Buy |
58,200
+1,700
| +3% | +$11.8K | ﹤0.01% | 1333 |
|
|
2021
Q1 | $472K | Buy |
56,500
+8,700
| +18% | +$72.2K | 0.01% | 1170 |
|
|
2020
Q4 | $334K | Sell |
47,800
-6,800
| -12% | -$45.9K | ﹤0.01% | 1171 |
|
|
2020
Q3 | $340K | Buy |
+54,600
| New | +$377K | 0.01% | 1052 |
|
Other funds holding VRNA
Steve Schonfeld's VRNA Position: Q4 2025 in Review
Steve Schonfeld sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 438,062 shares — an estimated $46.7M sold.
Steve Schonfeld first reported a position in VRNA in Q3 2020 and held it in 21 quarters. The position peaked at $46.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Steve Schonfeld reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Steve Schonfeld sold 438,062 Verona Pharma shares in Q4 2025, an estimated $46.7M.
- Steve Schonfeld first reported a position in Verona Pharma in Q3 2020 and held it in 21 quarters.
- Steve Schonfeld's Verona Pharma position peaked at $46.7M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.